Compare · AS vs SILO
AS vs SILO
Side-by-side comparison of Amer Sports Inc. (AS) and Silo Pharma Inc. (SILO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AS and SILO operate in Apparel (Consumer Discretionary), so they compete in similar markets.
- AS is the larger of the two at $17.62B, about 3879.5x SILO ($4.5M).
- SILO has been more active in the news (8 items in the past 4 weeks vs 4 for AS).
- AS has more recent analyst coverage (25 ratings vs 0 for SILO).
- Company
- Amer Sports Inc.
- Silo Pharma Inc.
- Price
- $31.59+1.15%
- $2.57+0.00%
- Market cap
- $17.62B
- $4.5M
- 1M return
- -
- -42.76%
- 1Y return
- -
- -72.85%
- Industry
- Apparel
- Apparel
- Exchange
- NYSE
- NASDAQ
- IPO
- 2024
- News (4w)
- 4
- 8
- Recent ratings
- 25
- 0
Latest AS
- Amendment: SEC Form SCHEDULE 13D/A filed by Amer Sports Inc.
- SEC Form 6-K filed by Amer Sports Inc.
- SEC Form 6-K filed by Amer Sports Inc.
- Amer Sports Reports Second Quarter 2026 Financial Results, Raises Full Year Revenue, Margin, and EPS Guidance
- Amer Sports, Inc. to Report Second Quarter 2026 Financial Results on August 18, 2026
- Chief Executive Officer Zheng Jie (James) exercised 500,000 units of Ordinary Shares at a strike of $7.68 and sold $17,210,450 worth of Ordinary Shares (500,000 units at $34.42) (SEC Form 4)
- Chief Strategy Officer Chen Wen-Chang (Victor) sold $465,764 worth of Ordinary Shares (13,075 units at $35.62), decreasing direct ownership by 8% to 149,821 units (SEC Form 4)
- CEO of Arc'teryx Equipment Haselden Stuart exercised 200,000 units of Ordinary Shares at a strike of $12.51 and sold $7,656,766 worth of Ordinary Shares (215,275 units at $35.57), closing all direct ownership in the company (SEC Form 4)
- SEC Form 144 filed by Amer Sports Inc.
- Chief Financial Officer Page Andrew E sold $3,867,726 worth of Ordinary Shares (105,230 units at $36.75) and exercised 97,485 units of Ordinary Shares at a strike of $14.19, decreasing direct ownership by 65% to 4,083 units (SEC Form 4)
Latest SILO
- Silo Pharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment
- Silo Pharma Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form 10-Q filed by Silo Pharma Inc.
- Silo Pharma Granted European Patent Covering Novel PTSD Therapy
- SEC Form EFFECT filed by Silo Pharma Inc.
- SEC Form 424B3 filed by Silo Pharma Inc.
- Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform
- SEC Form S-8 filed by Silo Pharma Inc.
- SEC Form S-3 filed by Silo Pharma Inc.